Latest News about MRK
Recent news which mentions MRK
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
December 29, 2022
From Benzinga
Want to Collect a Dividend Every Month Next Year? Buy These 3 High-Yielding Stocks
December 29, 2022
From Motley Fool
Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today?
December 28, 2022
From InvestorPlace
From Benzinga
The Surprising Investing Strategy That Made Money in a Horrendous 2022
December 27, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2022
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
This Stock Just Soared by 20%: Should You Buy Now?
December 26, 2022
From Motley Fool
$100 Invested In Merck & Co 5 Years Ago Would Be Worth This Much Today
December 23, 2022
Tickers
MRK
From Benzinga
From Benzinga
Merck COVID Antiviral Does Not Reduce Risk Of Hospitalization, Death Rates In Vaccinated Individuals
December 23, 2022
Tickers
MRK
From Benzinga
Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates
December 22, 2022
Tickers
MRK
From Benzinga
7 Drug Stocks That Will Soar in 2023
December 22, 2022
From InvestorPlace
7 Perfect Presents to Gift Your 2023 Stock Portfolio
December 21, 2022
From InvestorPlace
Delta and Moderna Share Good News
December 21, 2022
From Motley Fool
After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm
December 21, 2022
From Benzinga
Could This Opportunity Make Moderna a Hot Buy Again?
December 21, 2022
From Motley Fool
Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings
December 21, 2022
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
From InvestorPlace
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
From Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
December 20, 2022
From Motley Fool
What's Going On With Moderna Stock Monday?
December 19, 2022
From Benzinga
Are These Multibillion-Dollar Vaccine Stocks Still a Buy?
December 18, 2022
From Motley Fool
From Motley Fool
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
December 15, 2022
From MarketWatch
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
December 15, 2022
From Benzinga
From Benzinga
2 Dividend Stocks to Buy and Hold Through 2023 and Beyond
December 15, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
